AR017877A1 - Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo - Google Patents
Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodoInfo
- Publication number
- AR017877A1 AR017877A1 ARP980106418A ARP980106418A AR017877A1 AR 017877 A1 AR017877 A1 AR 017877A1 AR P980106418 A ARP980106418 A AR P980106418A AR P980106418 A ARP980106418 A AR P980106418A AR 017877 A1 AR017877 A1 AR 017877A1
- Authority
- AR
- Argentina
- Prior art keywords
- mastitis
- type
- mothers
- treatment
- xantofila
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Se describen un método para el tratamiento profiláctico de la mastitis en madres de mamíferos, inclusive madres humanas. El método comprende laadministracion a dichas madres de dosis profilácticamente efectivas de un medicamento humano o veterinarioque contiene por lo menos un tipo de xantofilas, talcomo la astaxantina. Preferentemente la astaxantina existe en una forma esterificada con ácidos grasos, por ejemplo, en la forma de una harina de algasproducida mediante el cultivo del algaHeamatoc occus sp. Además, se revela el uso de por lo menos un tipo de xantofinas, tal como la astaxantina, para lapreparacion de un medicamento humano o veterinario para el tratamiento profiláctico de la mastitis en madres de mamíferos, incluyendohumanas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704693A SE511237C2 (sv) | 1997-12-16 | 1997-12-16 | Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor |
Publications (1)
Publication Number | Publication Date |
---|---|
AR017877A1 true AR017877A1 (es) | 2001-10-24 |
Family
ID=20409414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980106418A AR017877A1 (es) | 1997-12-16 | 1998-12-16 | Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo |
Country Status (12)
Country | Link |
---|---|
US (1) | US6335015B1 (es) |
EP (1) | EP1049460B1 (es) |
JP (1) | JP2002508318A (es) |
AR (1) | AR017877A1 (es) |
AT (1) | ATE239457T1 (es) |
AU (1) | AU743198B2 (es) |
CA (1) | CA2314170C (es) |
DE (1) | DE69814467D1 (es) |
NO (1) | NO327301B1 (es) |
NZ (1) | NZ504801A (es) |
SE (1) | SE511237C2 (es) |
WO (1) | WO1999030701A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9903336D0 (sv) * | 1999-09-17 | 1999-09-17 | Astacarotene Ab | DNA construct and its use |
SE9903619D0 (sv) * | 1999-10-07 | 1999-10-07 | Astacarotene Ab | Use and method of treatment |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US20050059635A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
US7375133B2 (en) * | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
CA2495167C (en) | 2002-07-29 | 2018-08-21 | Hawaii Biotech, Inc. | Structural carotenoid analogs for the inhibition and amelioration of disease |
US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
EP1750723A1 (en) | 2004-04-14 | 2007-02-14 | Hawaii Biotech, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
NZ554476A (en) | 2004-09-28 | 2010-09-30 | Chemaphor Inc | Compositions and methods for promoting weight gain feed conversion |
US20060111580A1 (en) * | 2004-10-01 | 2006-05-25 | Lockwood Samuel F | Methods for the synthesis of chiral dihydroxy ketone intermediates useful for the chiral synthesis of carotenoids |
JP2011500733A (ja) | 2007-10-26 | 2011-01-06 | ケマファー インコーポレーテッド | 免疫応答を増強するための組成物および方法 |
WO2010124392A1 (en) * | 2009-04-30 | 2010-11-04 | Chemaphor Inc. | Methods, compositions, and kits for the treatment of inflammatory conditions |
AU2010242502B2 (en) | 2009-04-30 | 2016-11-10 | Avivagen Inc. | Methods and compositions for improving the health of animals |
EP4106547A4 (en) * | 2020-02-18 | 2024-03-13 | Avivagen Inc. | SUPPLEMENTED PET FOOD FOR MAMMALS |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2619491B2 (ja) | 1988-08-11 | 1997-06-11 | サントリー株式会社 | アスタキサンチン含有組成物 |
US5886053A (en) * | 1995-02-03 | 1999-03-23 | Basf Aktiengesellschaft | Use of carotenoids for producing drugs for the treatment of dermatoses |
JPH09124470A (ja) * | 1995-10-26 | 1997-05-13 | Suntory Ltd | 抗ストレス組成物 |
SE506191C2 (sv) * | 1996-03-27 | 1997-11-17 | Astacarotene Ab | Medel och sätt för att öka produktionen av/hos däggdjur |
-
1997
- 1997-12-16 SE SE9704693A patent/SE511237C2/sv not_active IP Right Cessation
-
1998
- 1998-12-10 AT AT98963702T patent/ATE239457T1/de not_active IP Right Cessation
- 1998-12-10 JP JP2000538684A patent/JP2002508318A/ja active Pending
- 1998-12-10 NZ NZ504801A patent/NZ504801A/en not_active IP Right Cessation
- 1998-12-10 CA CA002314170A patent/CA2314170C/en not_active Expired - Fee Related
- 1998-12-10 EP EP98963702A patent/EP1049460B1/en not_active Expired - Lifetime
- 1998-12-10 WO PCT/SE1998/002279 patent/WO1999030701A1/en active IP Right Grant
- 1998-12-10 DE DE69814467T patent/DE69814467D1/de not_active Expired - Lifetime
- 1998-12-10 AU AU18972/99A patent/AU743198B2/en not_active Ceased
- 1998-12-10 US US09/589,594 patent/US6335015B1/en not_active Expired - Lifetime
- 1998-12-16 AR ARP980106418A patent/AR017877A1/es unknown
-
2000
- 2000-06-14 NO NO20003042A patent/NO327301B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1999030701A1 (en) | 1999-06-24 |
DE69814467D1 (de) | 2003-06-12 |
SE511237C2 (sv) | 1999-08-30 |
SE9704693D0 (sv) | 1997-12-16 |
NZ504801A (en) | 2002-05-31 |
NO20003042L (no) | 2000-06-14 |
SE9704693L (sv) | 1999-06-17 |
ATE239457T1 (de) | 2003-05-15 |
NO20003042D0 (no) | 2000-06-14 |
NO327301B1 (no) | 2009-06-02 |
CA2314170C (en) | 2008-01-29 |
US6335015B1 (en) | 2002-01-01 |
EP1049460B1 (en) | 2003-05-07 |
JP2002508318A (ja) | 2002-03-19 |
CA2314170A1 (en) | 1999-06-24 |
AU1897299A (en) | 1999-07-05 |
EP1049460A1 (en) | 2000-11-08 |
AU743198B2 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR017877A1 (es) | Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo | |
UY26330A1 (es) | " método para mejorar la piel y el pelaje de mascotas". | |
ATE232393T1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung | |
DK1011653T3 (da) | Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser | |
ATE243030T1 (de) | Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen | |
ATE108334T1 (de) | Immunotherapeutisches zubereitungen für die behandlung von aids. | |
AR032248A1 (es) | Preparacion para mejorar la asimilacion de los alimentos | |
JP4755325B2 (ja) | 絹蛋白質加水分解物由来の生理活性作用組成物 | |
ATE274916T1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
DK165903C (da) | Farmaceutisk praeparat mod acne | |
ZA202306644B (en) | Application of chinese liquor in the preparation of medicines for improving intestinal barrier functions and gut microbiota | |
WO2020210712A3 (en) | Ir700 nanocompositions for cardiac therapies and applications | |
SE9803541D0 (sv) | Treatment of dyspepsia | |
SE9704590D0 (sv) | Method of increasing the production and improving the quality of semen | |
PT651654E (pt) | Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa | |
CN107510767A (zh) | 一种固肾补肾组合药物 | |
ATE395064T1 (de) | Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
ES2145114T3 (es) | Combinacion de atovacuona con proguanil para el tratamiento de infecciones protozoarias. | |
ES2112517T3 (es) | Antibioticos ge 37468 a, b y c. | |
Saha et al. | Mycobacterium chelonae infection complicating cosmetic facial surgery | |
ES2581180B1 (es) | Uso de aloe oral para la mejora capilar | |
AU2001278375A1 (en) | Composition for pharmaceutical and cosmetic products | |
Dharmapalan et al. | Nature Itself Is The Best Medicine–Herbal Local Drug Delivery In Periodontitis | |
CN111150779A (zh) | 一种治疗口腔溃疡的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |